{"nct_id":"NCT04414475","title":"A Study of Selinexor (Seli) + Low-dose Dexamethasone (LDD) in Penta-refractory Multiple Myeloma (MM), Seli and Bortezomib + LDD in Triple-class Refractory MM.","status":"RECRUITING","status_verified_date":"2025-09","start_date":"2020-07-01","start_date_type":"ACTUAL","primary_completion_date":"2028-01","primary_completion_date_type":"ESTIMATED","completion_date":"2028-01","completion_date_type":"ESTIMATED","phases":["PHASE2"],"tickers":["KPTI"]}